Protalix BioTherapeutics, Inc.
NYSE · Healthcare · Biological Products, (No Diagnostic Substances) · Hackensack, NJ
PLX chart
What traders are saying about $PLX
Latest postsProtalix BioTherapeutics, Inc. news
- Protalix BioTherapeutics Inc. (US74365A3095.SG) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- Protalix BioTherapeutics, Inc. (PLX) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Higher Single PRX-115 Doses Kept Plasma Uric Acid Levels Below Therapeutic Target for Longer Durations
Yahoo Finance ·
- Protalix BioTherapeutics to Announce Q3 2026 Earnings on November 10
Kalkine Media ·
- Protalix BioTherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November 10, 2026
Yahoo Finance ·
- Protalix BioTherapeutics to Present at the Stifel 2026 Healthcare Conference
Yahoo Finance ·
- Guerrilla RF Heads These 3 Top Penny Stocks To Watch
Yahoo Finance ·
- 3 Oil And Gas Stocks to Watch as Supply Shock Risks Rise
Yahoo Finance ·
- Netflix downgraded, SanDisk initiated: Wall Street's top analyst calls
Yahoo Finance ·
- Protalix BioTherapeutics to Participate in Upcoming September 2026 Investor Conferences
Yahoo Finance ·
- Protalix BioTherapeutics, Inc. Q2 2026 Earnings Call Summary
app.moby.co ·
- PLX: Elfabrio Estimates Up
Yahoo Finance ·
Protalix BioTherapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $52.7M | $53.4M | $65.5M | $47.6M |
| Net income | -$6.6M | $2.9M | $8.3M | -$14.9M |
| Diluted EPS | $-0.08 | $0.04 | $0.09 | $-0.31 |
| Total assets (year end) | $82.3M | $73.4M | $84.4M | $55.8M |
| Cash and equivalents (year end) | $14.7M | $19.8M | $23.6M | $17.1M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Protalix BioTherapeutics, Inc.
- Ticker
- PLX (NYSE)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Hackensack, NJ
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1006281
- Former names
- ORTHODONTIX INC, EMBASSY ACQUISITION CORP
Frequently asked questions
What exchange is Protalix BioTherapeutics, Inc. listed on?
Protalix BioTherapeutics, Inc. trades on the NYSE under the ticker symbol PLX.
What industry is Protalix BioTherapeutics, Inc. in?
Protalix BioTherapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Protalix BioTherapeutics, Inc. headquartered?
Protalix BioTherapeutics, Inc.'s business address on file with the SEC is in Hackensack, NJ.
When does Protalix BioTherapeutics, Inc.'s fiscal year end?
Protalix BioTherapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Protalix BioTherapeutics, Inc. report?
Protalix BioTherapeutics, Inc. reported $52.7M in revenue for calendar year 2025, according to its SEC filings.